No abstract available
Keywords:
CheckMate 743; Immune checkpoint; Immunotherapy; Malignant pleural mesothelioma; Mesothelioma.
MeSH terms
-
Clinical Trials as Topic
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use
-
Immunotherapy
-
Ipilimumab / therapeutic use
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Mesothelioma, Malignant / drug therapy*
-
Mesothelioma, Malignant / pathology
-
Nivolumab / therapeutic use
-
Pleural Neoplasms / drug therapy*
-
Pleural Neoplasms / pathology
-
Treatment Outcome
Substances
-
Immune Checkpoint Inhibitors
-
Ipilimumab
-
Nivolumab
Associated data
-
ClinicalTrials.gov/NCT04334759
-
ClinicalTrials.gov/NCT02784171
-
ClinicalTrials.gov/NCT03762018
-
ClinicalTrials.gov/NCT02709512